Published in Nature on April 13, 1978
Monoclonal cytolytic T-cell lines. J Exp Med (1979) 5.28
Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation. J Exp Med (1980) 4.47
Definition of T cell idiotypes using anti-idiotypic antisera produced by immunization with T cell clones. J Exp Med (1982) 2.14
Long-term culture of normal mouse B lymphocytes. Proc Natl Acad Sci U S A (1981) 1.94
Hybrid H-2 histocompatibility gene products assign domains recognized by alloreactive T cells. Proc Natl Acad Sci U S A (1983) 1.67
Crossreactive mixed lymphocyte reaction determinants recognized by cloned alloreactive T cells. Proc Natl Acad Sci U S A (1979) 1.39
T cell clones reactive with sperm whale myoglobin. Isolation of clones with specificity for individual determinants on myoglobin. J Exp Med (1981) 1.23
Multiple functional sites on a single Ia molecule defined using T cell clones and antibodies with chain-determined specificity. J Exp Med (1984) 1.18
Quantitative studies on T cell diversity. III. Limiting dilution analysis of precursor cells for T helper cells reactive to xenogeneic erythrocytes. J Exp Med (1982) 1.01
Functional helper activity of monoclonal T cell populations: antigen-specific and H-2 restricted cloned T cells provide help for in vitro antibody responses to trinitrophenyl-poly(LTyr,Glu)-poly(DLAla)--poly(LLys). Proc Natl Acad Sci U S A (1981) 0.96
T-cell clones and T-cell receptors. Microbiol Rev (1986) 0.90
T-cell responses to minor histocompatibility antigens. Immunology (1982) 0.89
Toward a molecular understanding of adaptive immunity: a chronology - part II. Front Immunol (2012) 0.87
Clonal analysis of F1 hybrid helper T cells restricted to parental or F1 hybrid major histocompatibility determinants. J Exp Med (1980) 0.85
Unique mixed lymphocyte-stimulating determinants in Ed alpha gene-introduced C57BL/6 transgenic mice. Immunology (1989) 0.80
The receptor specificity of alloreactive T cells. Distinction between stimulator K, I, and D region products and degeneracy of third-party H-2 recognition by low-affinity T cells. J Exp Med (1979) 0.77
A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell (2000) 17.61
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (1994) 11.22
Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature (1989) 7.52
Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (1994) 7.34
Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell (1991) 6.49
Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol (1996) 6.44
A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science (2000) 5.78
Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med (1998) 5.78
Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med (1989) 5.65
Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature (1990) 5.41
Control of early viral and bacterial distribution and disease by natural antibodies. Science (1999) 4.73
Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation. J Exp Med (1980) 4.47
Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J Virol (1994) 4.34
T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature (1988) 4.04
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature (2001) 3.99
Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods (1991) 3.78
Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur J Immunol (1998) 3.52
Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res (2000) 3.41
The influence of antigen organization on B cell responsiveness. Science (1993) 3.32
Immune responses in interleukin-2-deficient mice. Science (1993) 3.29
On immunity against infections and vaccines: credo 2004. Scand J Immunol (2004) 3.29
Fine specificity of a continuously growing killer cell clone specific for H-Y antigen. Eur J Immunol (1979) 3.27
IgA production without mu or delta chain expression in developing B cells. Nat Immunol (2001) 3.26
On immunological memory. Annu Rev Immunol (1996) 3.21
Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med (1998) 3.03
Decreased tumor surveillance in perforin-deficient mice. J Exp Med (1996) 3.00
Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol (1996) 2.96
Major histocompatibility complex--dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur J Immunol (1989) 2.71
Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature (1991) 2.66
Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev (1997) 2.58
Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J Exp Med (1990) 2.58
A non-retroviral RNA virus persists in DNA form. Nature (1997) 2.57
On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci U S A (1996) 2.55
The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol (1995) 2.47
Structure and function of human perforin. Nature (1988) 2.47
Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science (1988) 2.46
The role of antibody concentration and avidity in antiviral protection. Science (1997) 2.45
Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl Acad Sci U S A (1991) 2.41
Assignment of genes for immunoglobulin kappa and heavy chains to chromosomes 6 and 12 in mouse. Proc Natl Acad Sci U S A (1978) 2.38
Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell (1986) 2.38
The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides. J Exp Med (1990) 2.32
Abnormal migration of T lymphocyte clones. J Immunol (1982) 2.30
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (1996) 2.30
Intrathymic deletion of self-reactive cells prevented by neonatal anti-CD4 antibody treatment. Nature (1988) 2.28
Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected]. Nature (1996) 2.25
T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol (1993) 2.25
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int (1982) 2.24
Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Proc Natl Acad Sci U S A (1997) 2.23
Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J Exp Med (1992) 2.22
T cell-specific gamma genes in C57BL/10 mice. Sequence and expression of new constant and variable region genes. J Exp Med (1986) 2.20
A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc Natl Acad Sci U S A (1997) 2.20
Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci U S A (1999) 2.19
Definition of T cell idiotypes using anti-idiotypic antisera produced by immunization with T cell clones. J Exp Med (1982) 2.14
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol (2000) 2.13
Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J Exp Med (1997) 2.13
Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr Opin Immunol (1996) 2.11
Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. J Immunol (1993) 2.10
A central role of perforin in cytolysis? Annu Rev Immunol (1991) 2.08
T cell priming versus T cell tolerance induced by synthetic peptides. J Exp Med (1995) 2.07
Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur J Immunol (1986) 2.06
Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur J Immunol (1989) 2.05
Thymus cell maturation. II. Differentiation of three "mature" subclasses in vivo. Cell Immunol (1975) 2.04
Correlation of T cell receptor V beta gene family with MHC restriction. J Exp Med (1987) 2.04
Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science (1995) 2.01
CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol (1994) 2.00
The structure of T-cell epitopes. Annu Rev Immunol (1987) 1.99
Vaccination for disease. Science (1991) 1.97
T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. EMBO J (1989) 1.94
Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J Exp Med (1997) 1.93
In vitro secondary mixed leukocyte reaction (MLR). II. Interaction MLR determinants expressed by F1 cells. Eur J Immunol (1977) 1.90
Peptide-induced antiviral protection by cytotoxic T cells. Proc Natl Acad Sci U S A (1991) 1.89
Positive selection of CD4+ thymocytes controlled by MHC class II gene products. Nature (1988) 1.86
Regulation of the immune response by antigen. Science (2001) 1.84
Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. Immunity (1998) 1.83
T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today (1994) 1.81
Induction of long-lived germinal centers associated with persisting antigen after viral infection. J Exp Med (1996) 1.80
Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. Proc Natl Acad Sci U S A (1995) 1.79
T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages. J Exp Med (1990) 1.79
Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med (1999) 1.79
CD4+ T-cell-epitope escape mutant virus selected in vivo. Nat Med (2001) 1.78
Postnatal disappearance of self-reactive (V beta 6+) cells from the thymus of Mlsa mice. Implications for T cell development and autoimmunity. J Exp Med (1989) 1.78
Two monoclonal rat antibodies with specificity for the beta-chain variable region V beta 6 of the murine T-cell receptor. Proc Natl Acad Sci U S A (1988) 1.75
H-2 gene complementation in cytotoxic T cell responses of female against male cells. Eur J Immunol (1977) 1.75
Identical V beta T-cell receptor genes used in alloreactive cytotoxic and antigen plus I-A specific helper T cells. Nature (1985) 1.74
Preferential usage of V alpha 4 and V beta 10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells. Eur J Immunol (1990) 1.74
Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur J Immunol (1997) 1.73
CD4+ but not CD8+ cells are essential for allorejection. J Exp Med (1996) 1.72
Viral persistence in vivo through selection of neutralizing antibody-escape variants. Proc Natl Acad Sci U S A (2000) 1.72
Viral escape and the failure of cellular immune responses. Science (2000) 1.70
Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J Exp Med (1998) 1.70
Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol (1984) 1.68
Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant. J Exp Med (1984) 1.66
T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? Eur J Immunol (1995) 1.65
Ia alloantigen(s) detected on thymocytes by use of a fluorescence-activated cell sorter. J Immunol (1975) 1.65
Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur J Immunol (1995) 1.65
Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med (1998) 1.65
Modulation of CD4 by antigenic activation. J Immunol (1987) 1.63